Alcohol Biosensor Monitoring for Alcoholic Liver Disease

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 13, 2018

Primary Completion Date

February 28, 2021

Study Completion Date

June 28, 2021

Conditions
Alcohol Use, Unspecified
Interventions
BEHAVIORAL

Feedback

Participant will receive a brief feedback on alcohol use data downloaded from the ABM and information about treatment resources

BEHAVIORAL

Enhanced Usual Care

Participant will receive information on self reported alcohol use and information about remaining abstinent and about treatment resources

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Pittsburgh

OTHER

NCT03533660 - Alcohol Biosensor Monitoring for Alcoholic Liver Disease | Biotech Hunter | Biotech Hunter